OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VERUS$577.0057

Verusa Holding AS

Commodity ChemicalsVerified

Verusa Holding AS has a market capitalization of 40.11 billion TRY and a price-to-book ratio of 8.57, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 4.06, suggesting strong short-term liquidity, but its operating cash flow is negative at -167.12 million TRY, and free cash flow is also negative at -243.09 million TRY, signaling potential cash flow constraints. Profitability metrics show a return on equity of -6.26% and a return on assets of -3.63%, both significantly below the industry norms for Commodity Chemicals, which typically exhibit positive returns. The company's net income is negative at -293.21 million TRY, despite a gross profit of 966.90 million TRY and operating income of 554.86 million TRY, indicating high operating and non-operating expenses. Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data, but the absence of segment-specific revenue breakdowns suggests a lack of diversification or transparency in its business operations. The company's exposure to geographic and product-specific risks remains unclear without further disclosure. Looking ahead, the company's revenue is expected to remain under pressure, with no clear growth trajectory outlined in the available data. The capital expenditure of -33.69 million TRY and the negative free cash flow suggest that the company is not currently generating sufficient cash to fund its operations or expansion without external financing. The risk assessment highlights a medium liquidity risk and a low dilution risk. However, the company's net cash position is negative after subtracting total debt, which could lead to increased financial leverage and potential refinancing needs. The debt-to-equity ratio of 0.21 is relatively low, but the negative net income and cash flow metrics suggest that the company may face challenges in maintaining its current capital structure. Recent events and filings do not provide specific details on strategic initiatives or operational changes, but the company's ESG profile is mixed, with a high ESG controversies score of 100.00, indicating a lack of controversies, but a low governance score of 4.80, suggesting potential governance concerns.

30-day price · VERUS+80.00 (+16.0%)
Low$459.00High$600.00Close$580.00As of25 May, 00:00 UTC
Profile
CompanyVerusa Holding AS
TickerVERUS.IS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Verusa Holding AS operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods.

Classification. Verusa is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Verusa Holding AS has a market capitalization of 40.11 billion TRY and a price-to-book ratio of 8.57, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 4.06, suggesting strong short-term liquidity, but its operating cash flow is negative at -167.12 million TRY, and free cash flow is also negative at -243.09 million TRY, signaling potential cash flow constraints. Profitability metrics show a return on equity of -6.26% and a return on assets of -3.63%, both significantly below the industry norms for Commodity Chemicals, which typically exhibit positive returns. The company's net income is negative at -293.21 million TRY, despite a gross profit of 966.90 million TRY and operating income of 554.86 million TRY, indicating high operating and non-operating expenses. Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data, but the absence of segment-specific revenue breakdowns suggests a lack of diversification or transparency in its business operations. The company's exposure to geographic and product-specific risks remains unclear without further disclosure. Looking ahead, the company's revenue is expected to remain under pressure, with no clear growth trajectory outlined in the available data. The capital expenditure of -33.69 million TRY and the negative free cash flow suggest that the company is not currently generating sufficient cash to fund its operations or expansion without external financing. The risk assessment highlights a medium liquidity risk and a low dilution risk. However, the company's net cash position is negative after subtracting total debt, which could lead to increased financial leverage and potential refinancing needs. The debt-to-equity ratio of 0.21 is relatively low, but the negative net income and cash flow metrics suggest that the company may face challenges in maintaining its current capital structure. Recent events and filings do not provide specific details on strategic initiatives or operational changes, but the company's ESG profile is mixed, with a high ESG controversies score of 100.00, indicating a lack of controversies, but a low governance score of 4.80, suggesting potential governance concerns.
Key takeaways
  • Verusa Holding AS is trading at a high price-to-book ratio of 8.57, indicating a premium valuation.
  • The company's return on equity is -6.26%, significantly below industry norms for Commodity Chemicals.
  • The company has a negative net income of -293.21 million TRY despite positive gross and operating profits.
  • The company's liquidity position is strong with a current ratio of 4.06, but its operating and free cash flows are negative.
  • The company's ESG governance score is low at 4.80, indicating potential governance concerns.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$1.77B
Gross profit$966.9M
Operating income$554.9M
Net income-$293.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$167.1M
CapEx-$33.7M
Free cash flow-$243.1M
Total assets$8.08B
Total liabilities$3.40B
Total equity$4.68B
Cash & equivalents$27.1M
Long-term debt$977.3M
Valuation
Market price$577.00
Market cap$40.11B
Enterprise value$41.06B
P/E
Reported non-GAAP P/E
EV/Revenue23.2
EV/Op income74.0
EV/OCF
P/B8.6
P/Tangible book8.6
Tangible book$4.68B
Net cash-$950.2M
Current ratio4.1
Debt/Equity0.2
ROA-3.6%
ROE-6.3%
Cash conversion57.0%
CapEx/Revenue-1.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricVERUSActivity
Op margin31.4%8.0% medp25 -2.2% · p75 23.4%top quartile
Net margin-16.6%5.5% medp25 -3.8% · p75 18.5%bottom quartile
Gross margin54.7%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.9%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity21.0%37.1% medp25 10.3% · p75 82.0%below median
Observations
IR observations
Social pillar17.56 (0-100)
Governance pillar4.80 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 02:50 UTC#3f0624b8
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 22:10 UTCJob: bb2c5f7b